Valvular & structural heart diseaseCohort study

Mitral Regurgitation and Severe Aortic Stenosis: Clinical Characteristics, Prognostic Impact, and Response to Transcatheter Aortic Valve Replacement (TAVR): Insights From Egnite Data

Circ Cardiovasc IntervPublished

  • Retrospective analysis of a multicentre echocardiography database
  • 43 US institutions
  • Egnite Database

Authors' conclusion

Patients with concurrent MR and AS exhibit substantially higher mortality yet have high rates of undertreatment throughout the duration of follow-up. TAVR alone significantly improves MR in most patients.

Study context

Population
Adults (aged ≥18 years) with severe aortic stenosis (AS) and moderate or greater mitral regurgitation (MR)cohort with severe AS and moderate or greater MR, identified from 2,992,362 patients undergoing 5,245,904 echocardiograms
Participants
36,402 adults
Exposure
untreated vs TAVR alone vs surgery or other transcatheter interventions
Outcome
All-cause mortality in untreated patients, by MR severity
Follow-up
2 years

Main finding

As reported in the abstract

Observational data: associations, not effects.

Further findings

Treatment distribution

OutcomeundertreatmentP value
Undertreatment, AS with significant MR versus without · more frequent in patients with AS and significant MR64.5% versus 49.9%P < 0.001
Treatment distribution — mean age
78.2 years
Treatment distribution — male
54.6%

Improvement in MR after TAVR alone (patients with follow-up MR data) · 45 days post-TAVR

demonstrated improvement in MR
77.5%
  • visualized using Sankey diagrams

Original publication

Mitral Regurgitation and Severe Aortic Stenosis: Clinical Characteristics, Prognostic Impact, and Response to TAVR: Insights From Egnite Data. Circ Cardiovasc Interv. Published 11 September 2026. doi:10.1161/circinterventions.126.016578

Summarised from the published abstract; every number is checked against it